(Total Views: 77)
Posted On: 12/06/2022 8:20:50 AM
Post# of 224618

$CGEN News Article - Compugen's COM701 (anti-PVRIG) in Dual and Triple Combination Demonstrates Preliminary Durable Anti-Tumor Activity and Immune Activation in Patients with Platinum Resistant Ovarian Cancer https://marketwirenews.com/news-releases/comp...04643.html


My Twitter: WhyteStocks